📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

LUPINPharmaceuticals

Lupin Ltd — Financial Ratios & Key Metrics

₹2313.90

-0.66%

P/E Ratio22.00xIndustry: 31.77x

ROE20.62%Return on equity

ROCE21.30%Return on capital

Debt/Equity0.32Low debt

💎

Valuation & Profitability

P/E Ratio

22.00x

Industry Average P/E

31.77x

Dividend Yield

0.58%

Market Cap

₹95.15K (Cr)

Sales Growth 5Y

8.11%

Profit Growth 5Y

54.88%

EPS Growth 5Y

54.69%

OPM 5Y Avg

14.94%

📉

Price Returns

1 Month

+6.03%

3 Months

+10.17%

6 Months

+7.09%

1 Year

+1.52%

52W Low

₹1795

Current

₹2314

52W High

₹2378

89% of 52-week range — Near highs

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹2242

▲ Price above SMA 50 — Bullish

SMA 200

₹2055

▲ Long-term uptrend

Volume Signal

104% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Lupin Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.